Literature DB >> 27347202

Protection of organs at risk during neoadjuvant chemoradiotherapy for gastric cancer based on a comparison between conformal and intensity-modulated radiation therapy.

Leszek Hawrylewicz1, Wojciech Leszczyński1, Agnieszka Namysł-Kaletka2, Iwona Bronclik1, Jerzy Wydmański2.   

Abstract

The aim of the present study was to compare the techniques of dynamic intensity-modulated radiation therapy (IMRT) and three-dimensional conformal radiotherapy (3DCRT) in patients with gastric cancer. Implementation of the IMRT technique does not significantly affect the minimum and maximum dose levels in the planning target volume (PTV), but more effectively protects the critical organs. The study group consisted of 25 patients. The results of the analysis of the conformity index (CI) and the homogeneity index (HI) showed that the doses in the PTV regions were at a comparable level. The CI for the PTV was 0.95 for the 2-field technique, 0.95 for the 3-field technique, 0.96 for the 4-field technique and 0.94 for the IMRT technique. The CIs for these techniques for the clinical target volume (CTV) were 0.96, 0.96, 0.97 and 0.96, respectively, and the CIs for the gross tumor volume (GTV) were 0.99, 0.99, 0.99 and 0.98, respectively. The HI values for the PTV were 1.12 for the 2-field technique, 1.12 for the 3-field technique, 1.09 for the 4-field technique and 1.09 for the IMRT technique, and the HI values for the CTV were 1.12, 1.12, 1.09 and 1.08 for the same techniques, respectively. The HI values for the GTV were 1.09, 1.09, 1.07 and 1.06, respectively, which indicated significantly superior performance in the regions of healthy tissue. Statistical study was based on Friedman's rank analysis of variance to determine the level of reliability of the tested groups of variables (P<0.001). The present study demonstrated that the IMRT technique in the pre-operative radiotherapy of gastric cancer patients results in superior treatment tolerance and reduces the risk of damage to healthy tissue that is in close proximity to the irradiated area.

Entities:  

Keywords:  gastric cancer; intensity-modulated radiation therapy; neoadjuvant chemoradiotherapy; protection of organ at risk; radiation therapy; three-dimensional conformal radiation therapy

Year:  2016        PMID: 27347202      PMCID: PMC4907308          DOI: 10.3892/ol.2016.4633

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  20 in total

1.  Comparison of dosiology between three dimensional conformal and intensity-modulated radiotherapies (5 and 7 fields) in gastric cancer post-surgery.

Authors:  Hong Ma; Jun Han; Tao Zhang; Yang Ke
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-10-20

2.  Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients.

Authors:  Z X Zhang; X Z Gu; W B Yin; G J Huang; D W Zhang; R G Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-12-01       Impact factor: 7.038

3.  Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.

Authors:  E Shaw; C Scott; L Souhami; R Dinapoli; R Kline; J Loeffler; N Farnan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-05-01       Impact factor: 7.038

4.  Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.

Authors:  A Yuriko Minn; Annie Hsu; Trang La; Pamela Kunz; George A Fisher; James M Ford; Jeffrey A Norton; Brendan Visser; Karyn A Goodman; Albert C Koong; Daniel T Chang
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

5.  EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

Authors:  Milena Sant; Claudia Allemani; Mariano Santaquilani; Arnold Knijn; Francesca Marchesi; Riccardo Capocaccia
Journal:  Eur J Cancer       Date:  2009-01-24       Impact factor: 9.162

6.  Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma.

Authors:  J A Ajani; P F Mansfield; N Janjan; J Morris; P W Pisters; P M Lynch; B Feig; R Myerson; R Nivers; D S Cohen; L L Gunderson
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

Review 7.  EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach.

Authors:  Oscar Matzinger; Erich Gerber; Zvi Bernstein; Philippe Maingon; Karin Haustermans; Jean François Bosset; Akos Gulyban; Philip Poortmans; Laurence Collette; Abraham Kuten
Journal:  Radiother Oncol       Date:  2009-04-15       Impact factor: 6.280

Review 8.  Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review.

Authors:  A G Morganti; A Di Castelnuovo; M Massaccesi; F Cellini; S Cilla; G Macchia; P Forte; M Buwenge; C Digesu; M Ferro; V Picardi; L Caravatta; V Valentini; F Deodato
Journal:  Br J Radiol       Date:  2013-07-26       Impact factor: 3.039

9.  Quantifying the degree of conformity in radiosurgery treatment planning.

Authors:  Nicoletta J Lomax; Stefan G Scheib
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-04-01       Impact factor: 7.038

10.  Evaluation of stereotactic radiosurgery conformity indices for 170 target volumes in patients with brain metastases.

Authors:  Julia Stanley; Karen Breitman; Peter Dunscombe; David P Spencer; Harold Lau
Journal:  J Appl Clin Med Phys       Date:  2011-02-01       Impact factor: 2.102

View more
  2 in total

1.  18-Fluorodeoxy-Glucose Positron Emission Tomography- Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy

Authors:  Kinga Dębiec; Jerzy Wydmański; Izabela Gorczewska; Paulina Leszczyńska; Kamil Gorczewski; Wojciech Leszczyński; Andrea d’Amico; Michał Kalemba
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

Review 2.  Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?

Authors:  Jen-Hao Yeh; Yung-Sung Yeh; Hsiang-Lin Tsai; Ching-Wen Huang; Tsung-Kun Chang; Wei-Chih Su; Jaw-Yuan Wang
Journal:  Cancers (Basel)       Date:  2022-06-20       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.